The Social Security Administration confirmed a 2.8% cost-of-living adjustment for 2026, which works out to roughly $56 a month for the average retiree. That is a tank of gas, a co-pay, maybe a modest grocery run, well short of a raise you can build a retirement plan around. If you want income that actually keeps up with your bills, you have to build it yourself. Three dividend ETFs do the heavy lifting for you: the Vanguard Dividend Appreciation ETF (NYSEARCA:VIG), the ProShares S&P 500 Dividend Aristocrats ETF (BATS:NOBL), and the First Trust Rising Dividend Achievers ETF (NASDAQ:RDVY).
Each one solves a slightly different piece of the same problem: a fixed income that is not keeping pace with real life.
Why $56 a Month Falls Short
Grocery prices, Medicare Part B, homeowners insurance, and property taxes have all outrun the CPI-W basket that drives the COLA formula. While a 2.8% bump on the average benefit is a good starting point, it is a rearview-mirror adjustment. Dividend growth ETFs let you build a second raise on top of it: one that compounds, and one that you control.
VIG: The Low-Cost Anchor
Vanguard’s dividend appreciation fund tracks companies with long records of raising their payouts. What makes it a core holding is its ultra-low headline fee. VIG charges an expense ratio of just 0.04%, meaning $9,996 out of every $10,000 you invest stays working for you. The fund is enormous, with net assets of roughly $124.7 billion as of April 2026, so liquidity is not a concern.
The income is real and rising. VIG paid $3.58 per share over the trailing 12 months, up from $2.13 in 2019. At a recent price of $245.23, that is a modest current yield, but the direction matters more than the starting point. Total return has kept up too: the ETF is up 12.5% year to date and 246.13% over the past ten years.
NOBL: The 25-Year Rule
NOBL holds only S&P 500 members that have raised their dividend for at least 25 consecutive years. That filter is unforgiving, and it produces a portfolio that leans toward consumer staples, industrials, and healthcare rather than tech. Top positions include Nucor at 1.76%, West Pharmaceutical at 1.72%, and IBM at 1.71%, with no single holding above 1.76%. Net assets sit at $11.07 billion.
NOBL paid $2.03 per share over the trailing 12 months, and the fund has climbed 13.43% year to date. It is the defensive leg of this three-fund stool. When markets get choppy, boring dividend growers with 25-year payment streaks tend to hold up better than the index average.
RDVY: The Growth-Tilted Kicker
RDVY takes a different approach. It targets companies with strong earnings, low payout ratios, and rising dividends, which lets it hold newer dividend payers that NOBL cannot. That is why you see Lam Research at 3.35%, Applied Materials at 3.14%, and Alphabet at 2.32% alongside banks and insurers. Net assets are $19.85 billion.
The trade-off shows up in the payout. The trailing 12-month distribution was $0.677 per share, resulting in a lower yield than NOBL or VIG. Instead, you are paying for growth. On this front, it has delivered: RDVY is up 20.48% year to date, 32.62% over the past year, and 352.57% over the past decade.
The Real Trade-Off
Dividend ETFs are equities and carry equity risk. A retiree who moves too much of a fixed-income portfolio into VIG, NOBL, or RDVY takes on real drawdown risk in the next bear market. RDVY’s semiconductor tilt in particular can swing hard when the cycle turns. The right allocation is the one you can hold through a bad year without selling.
Still, if the goal is to turn a $56 monthly COLA into an income stream that keeps rising on its own, these three funds do what Congress will not. They give you a raise you can count on.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks